Literature DB >> 35701117

[Inhibition connexin 43 by mimetic peptide Gap27 mediates protective effects on 6-hydroxydopamine induced Parkinson's disease mouse model].

H H Quan1, W X Xu1, Y Z Qi1, Q R Li1, H Zhou1, J Huang1.   

Abstract

OBJECTIVE: To explore whether the using of mimetic peptide Gap27, a selective inhibitor of connexin 43 (Cx43), could block the death of dopamine neurons and influence the expression of Cx43 in 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease mouse models.
METHODS: Eighteen C57BL/6 mice were randomly divided into control group, 6-OHDA group and 6-OHDA+Gap27 group, with 6 mice in each group. Bilateral substantia nigra stereotactic injection was performed. The control group was injected with ascorbate solution, 6-OHDA group was injected with 6-OHDA solution, and 6-OHDA+Gap27 group was injected with 6-OHDA and Gap27 mixed solution. Immuno-histochemical staining was used to detect the number of dopamine neurons, quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of Cx43 messenger ribonucleic acid (mRNA), immuno-fluorescence staining was used to detect the distribution of Cx43 protein, the contents of Cx43 protein and Cx43 phosphorylation at serine 368 (Cx43-ps368) in mouse midbrain were detected by Western blot.
RESULTS: After injection of 6-OHDA, numerous dopamine neurons in substantia nigra died as Cx43 content increased, Cx43-ps368 content decreased. Mixing Gap27 while injecting 6-OHDA could reduce the number of death dopamine neurons and weaken the changes of Cx43 and Cx43-ps368 content caused by 6-OHDA. The number of tyrosine hydroxylase (TH) immunoreactive positive neurons in 6-OHDA group decreased to 27.7% ± 0.02% of the control group (P < 0.01); The number of TH immunoreactive positive neurons in 6-OHDA+Gap27 group was (1.64±0.16) times higher than that in 6-OHDA group (P < 0.05); The content of total Cx43 protein in 6-OHDA group was (1.44±0.07) times higher than that in 6-OHDA+Gap27 group (P < 0.05) while (1.68±0.07) times higher than that in control group (P < 0.01). In 6-OHDA group, the content of Cx43-ps368 protein and its proportion in total Cx43 protein were significantly lower than that in 6-OHDA+Gap27 group (P < 0.05).
CONCLUSION: In 6-OHDA mouse models, mimetic peptide Gap27 played a protective role in reducing the damage to substantia nigra dopamine neurons, which was induced by 6-OHDA. The overexpression of Cx43 protein might have neurotoxicity to dopamine neuron. Meanwhile, decreasing Cx43 protein level and keeping Cx43-ps368 protein level may be the protective mechanisms of Gap27.

Entities:  

Keywords:  6-hydroxydopamine; Connexin 43; Parkinson's disease; Peptide Gap27

Mesh:

Substances:

Year:  2022        PMID: 35701117      PMCID: PMC9197703     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  19 in total

Review 1.  Astrocytes in neurodegenerative disease.

Authors:  Hemali Phatnani; Tom Maniatis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-15       Impact factor: 10.005

Review 2.  Mimetic peptides as blockers of connexin channel-facilitated intercellular communication.

Authors:  W Howard Evans; Luc Leybaert
Journal:  Cell Commun Adhes       Date:  2007 Nov-Dec

Review 3.  Parkinson's Disease and Parkinsonism.

Authors:  Michael T Hayes
Journal:  Am J Med       Date:  2019-03-16       Impact factor: 4.965

4.  Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.

Authors:  Zhi-Yong Wang; Hui Lian; Li Zhou; Yi-Min Zhang; Qing-Qing Cai; Li-Fei Zheng; Jin-Xia Zhu
Journal:  J Parkinsons Dis       Date:  2016-05-05       Impact factor: 5.568

5.  Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation.

Authors:  Jose F Ek-Vitorin; Timothy J King; Nathanael S Heyman; Paul D Lampe; Janis M Burt
Journal:  Circ Res       Date:  2006-05-18       Impact factor: 17.367

6.  Regulation of connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTP-lesioned, FGF-2-treated parkinsonian mice.

Authors:  M Rufer; S B Wirth; A Hofer; R Dermietzel; A Pastor; H Kettenmann; K Unsicker
Journal:  J Neurosci Res       Date:  1996-12-01       Impact factor: 4.164

7.  Modulation of connexin 43 in rotenone-induced model of Parkinson's disease.

Authors:  A Kawasaki; T Hayashi; K Nakachi; J E Trosko; K Sugihara; Y Kotake; S Ohta
Journal:  Neuroscience       Date:  2009-02-13       Impact factor: 3.590

Review 8.  Intracellular trafficking pathways of Cx43 gap junction channels.

Authors:  Irina Epifantseva; Robin M Shaw
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-05-30       Impact factor: 3.747

9.  The Connexin Mimetic Peptide Gap27 and Cx43-Knockdown Reveal Differential Roles for Connexin43 in Wound Closure Events in Skin Model Systems.

Authors:  Chrysovalantou Faniku; Erin O'Shaughnessy; Claire Lorraine; Scott R Johnstone; Annette Graham; Sebastian Greenhough; Patricia E M Martin
Journal:  Int J Mol Sci       Date:  2018-02-18       Impact factor: 5.923

10.  Apelin-13 Suppresses Neuroinflammation Against Cognitive Deficit in a Streptozotocin-Induced Rat Model of Alzheimer's Disease Through Activation of BDNF-TrkB Signaling Pathway.

Authors:  Huaiqing Luo; Yang Xiang; Xiangping Qu; Huijun Liu; Chi Liu; Guangyi Li; Li Han; Xiaoqun Qin
Journal:  Front Pharmacol       Date:  2019-04-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.